SYMBICORT Side Effects

7022208-1 | Dysphonia, Pyrexia, Rash
on Sep 21, 2010 Female patient from JAPAN , 60 years of age, was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: dysphonia, pyrexia, rash (What is rash?). Symbicort dosage: . Patient was hospitalized.

7020442-8 | Dyspnoea, Fall, Musculoskeletal Pain, Nasopharyngitis, Upper Limb Fracture, Wheezing
Patient was taking Symbicort (View Usage). Patient had the following side effects: dyspnoea, fall (What is fall?), musculoskeletal pain, nasopharyngitis, upper limb fracture, wheezing on Sep 20, 2010 from BRAZIL Additional patient health information: Female patient , 58 years of age, weighting 136.7 lb, was diagnosed with asthma (What is asthma?), pain (What is pain?), depression (What is depression?), panic disorder (What is panic disorder?) and. Symbicort dosage: 320/9 Mcg, 320/9 Mcg Prn. During the same period patient was treated with ANADOR (View Anador Review and Anador Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LORAX (View Lorax Review and Lorax Label ). Patient was hospitalized.

7017942-3 | Pneumonia
Adverse event was reported on Sep 17, 2010 by a Female patient taking Symbicort (View Usage) (Dosage: 160/4.5 Mcg, Two Puffs) was diagnosed with emphysema and. Location: UNITED STATES , weighting 108.0 lb, After Symbicort was administered, patient had the following side effects: pneumonia (What is pneumonia?). During the same period patient was treated with LANOXIN (View Lanoxin Review and Lanoxin Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), XOPENEX (View Xopenex Review and Xopenex Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ). Patient was hospitalized.

7015087-X | Asthma
on Sep 23, 2010 Female patient from UNITED STATES , child 6 years of age, was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?). Symbicort dosage: .


7011854-7 | Cardiac Fibrillation, Retinal Infarction
on Sep 14, 2010 Male patient from UNITED STATES , 75 years of age, was diagnosed with emphysema and was treated with Symbicort (View Usage). Patient had the following side effects: cardiac fibrillation, retinal infarction. Symbicort dosage: 160/4.5 2 Puffs.

7007686-6 | Hyperglycaemia, Renal Failure Chronic
Patient was taking Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: hyperglycaemia, renal failure chronic on Sep 13, 2010 from UNITED STATES Additional patient health information: Female patient , 50 years of age, weighting 149.9 lb, was diagnosed with dyspnoea, anxiety (What is anxiety?), hypertension and. Symbicort dosage: 160/4.5 Ug Two Puffs. During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ), BENICAR HCT (View Benicar Hct Review and Benicar Hct Label ).

7007495-8 | Duodenal Ulcer
Adverse event was reported on Sep 13, 2010 by a Male patient taking Symbicort (View Usage) (Dosage: 160/4.5) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 78 years of age, Patient experienced the following unwanted or unexpected effects: duodenal ulcer. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), DIOVAN (View Diovan Review and Diovan Label ), BUMEX (View Bumex Review and Bumex Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), VICODIN (View Vicodin Review and Vicodin Label ), TRICOR (View Tricor Review and Tricor Label ). Patient was hospitalized.

7006498-7 | Asthma, Device Malfunction
on Sep 21, 2010 Female patient from UNITED STATES , 70 years of age, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). Patient had the following side effects: asthma (What is asthma?), device malfunction. Symbicort dosage: Inhale 2 Puffs Twice A Day.

7004261-4 | Asthma, Collapse Of Lung, Herpes Zoster, Pneumonia
on Sep 10, 2010 Female patient from UNITED STATES , 61 years of age, weighting 158.1 lb, was diagnosed with asthma (What is asthma?), herpes zoster, hypertension and was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: asthma (What is asthma?), collapse of lung, herpes zoster, pneumonia (What is pneumonia?). Symbicort dosage: 320 Mcg Bid. During the same period patient was treated with ALBUTEROL (Every 4 Hours Prn) (View Albuterol Review and Albuterol Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

7003225-4 | Ovarian Cancer, Pyrexia
Patient was taking Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian cancer, pyrexia on Sep 16, 2010 from UNITED STATES Additional patient health information: Female patient , 73 years of age, was diagnosed with asthma (What is asthma?), pneumonia (What is pneumonia?), cough and. Symbicort dosage: 80/4.5 Two Puffs. During the same period patient was treated with POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MOXIFLOXACIN (View Moxifloxacin Review and Moxifloxacin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), PROAIR HFA (As Needed) (View Proair Hfa Review and Proair Hfa Label ). Patient was hospitalized.

6991832-4 | Product Packaging Quantity Issue
Adverse event was reported on Sep 16, 2010 by a Female patient taking Symbicort (View Usage) (Dosage: 2 Puffs Twice Daily Inhalations By Mouth) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , weighting 187.0 lb, Patient had the following side effects: product packaging quantity issue.

6987470-X | Cardiac Disorder, Dyspnoea, Heart Rate Abnormal
on Sep 08, 2010 Female patient from UNITED STATES , 74 years of age, weighting 121.9 lb, was diagnosed with dyspnoea and was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: cardiac disorder, dyspnoea, heart rate abnormal. Symbicort dosage: 2 Puff, 320 Mcg Bid. During the same period patient was treated with COMBIVENT (3 Puffs Three Times A Day) (View Combivent Review and Combivent Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), PACERONE (View Pacerone Review and Pacerone Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

6979644-9 | Arthralgia, Weight Bearing Difficulty
on Sep 10, 2010 Female patient from UNITED STATES , 59 years of age, weighting 213.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, weight bearing difficulty. Symbicort dosage: 2 Oral Inhalation Twice Daily.

6973684-1 | Hypokalaemia, Pharyngitis, Pneumonia
Patient was taking Symbicort (View Usage). Patient had the following side effects: hypokalaemia, pharyngitis, pneumonia (What is pneumonia?) on Aug 31, 2010 from JAPAN Additional patient health information: Female patient , 62 years of age, weighting 103.6 lb, was diagnosed with asthma (What is asthma?) and. Symbicort dosage: . During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), MEDICON (View Medicon Review and Medicon Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ).

6970347-3 | Hypertension, Palpitations, Syncope
Adverse event was reported on Aug 30, 2010 by a Female patient taking Symbicort (View Usage) (Dosage: 160/4.5 Mcg Two Puffs) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , 41 years of age, weighting 239.0 lb, After Symbicort was administered, patient had the following side effects: hypertension, palpitations, syncope. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6969570-3 | Abasia, Muscle Spasms
on Sep 07, 2010 Female patient from UNITED STATES , 46 years of age, weighting 180.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, muscle spasms. Symbicort dosage: 2 Puffs Twice Daily Po. Patient was hospitalized.

6968612-9 | Arterial Occlusive Disease, Myocardial Infarction
on Aug 26, 2010 Male patient from UNITED STATES , weighting 155.0 lb, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). Patient had the following side effects: arterial occlusive disease, myocardial infarction. Symbicort dosage: 160 Mcg. During the same period patient was treated with MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

6968202-8 | Asthenia, Pain In Extremity
Patient was taking Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: asthenia, pain in extremity on Aug 27, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 147.9 lb, was diagnosed with asthma (What is asthma?), cough and. Symbicort dosage: 160/4.5. During the same period patient was treated with ROBITUSSON WITH CODEINE (View Robitusson With Codeine Review and Robitusson With Codeine Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), ALBUTEROL (Prn) (View Albuterol Review and Albuterol Label ).

6967950-3 | Asbestosis, Chronic Obstructive Pulmonary Disease, Pneumonia
Adverse event was reported on Aug 26, 2010 by a Male patient taking Symbicort (View Usage) (Dosage: 320 Ug Bid) was diagnosed with chronic obstructive pulmonary disease, asbestosis and. Location: UNITED STATES , 78 years of age, weighting 205.0 lb, Patient experienced the following unwanted or unexpected effects: asbestosis, chronic obstructive pulmonary disease, pneumonia (What is pneumonia?). During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), FEXOFENADINE HCL (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6956581-7 | Lung Disorder, Visual Impairment
on Aug 19, 2010 Male patient from UNITED STATES , weighting 330.0 lb, was treated with Symbicort (View Usage). Patient had the following side effects: lung disorder, visual impairment. Symbicort dosage: 160/4.5, 2 Puffs Bid. During the same period patient was treated with PULMICORT RESPULES (View Pulmicort Respules Review and Pulmicort Respules Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), BROVANA (View Brovana Review and Brovana Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), VITAMINS (View Vitamins Review and Vitamins Label ), COMBIVENT (View Combivent Review and Combivent Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

6956472-1 | Myocardial Infarction
on Aug 25, 2010 Male patient from UNITED STATES , 60 years of age, was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: myocardial infarction. Symbicort dosage: . During the same period patient was treated with COMBIVENT (View Combivent Review and Combivent Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ).

6956096-6 | Coronary Artery Disease, International Normalised Ratio Decreased
Patient was taking Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery disease (What is coronary artery disease?), international normalised ratio decreased on Aug 19, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 254.0 lb, was diagnosed with chronic obstructive pulmonary disease and. Symbicort dosage: 160/4.5 Ug 2 Puffs Twice A Day. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), FISHOILS (View Fishoils Review and Fishoils Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GLUCOSAMINE/CHONDROITIN (View Glucosamine/chondroitin Review and Glucosamine/chondroitin Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ).

6955973-X | Ovarian Cancer, Pyrexia
Adverse event was reported on Aug 25, 2010 by a Female patient taking Symbicort (View Usage) (Dosage: 80/4.5 Two Puffs) was diagnosed with asthma (What is asthma?), pneumonia (What is pneumonia?), cough and. Location: UNITED STATES , 73 years of age, Patient had the following side effects: ovarian cancer, pyrexia. During the same period patient was treated with POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MOXIFLOXACIN (View Moxifloxacin Review and Moxifloxacin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), PROAIR HFA (As Needed) (View Proair Hfa Review and Proair Hfa Label ). Patient was hospitalized.

6955252-0 | Arrhythmia, Dizziness, Loss Of Consciousness
on Aug 19, 2010 Male patient from PERU , 88 years of age, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), dizziness (What is dizziness?), loss of consciousness. Symbicort dosage: 160/4.5. Patient was hospitalized.

6955146-0 | Arterial Occlusive Disease, Blood Pressure Inadequately Controlled, Constipation, Cough, Labyrinthitis
on Aug 20, 2010 Female patient from BRAZIL , 46 years of age, weighting 176.4 lb, was diagnosed with asthma (What is asthma?), hypertension, hypothyroidism, anxiety (What is anxiety?) and was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: arterial occlusive disease, blood pressure inadequately controlled, constipation (What is constipation?), cough, labyrinthitis. Symbicort dosage: 160/4.5 Mcgs. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ), SYNTHROID (Od) (View Synthroid Review and Synthroid Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), PLAVIX (Od) (View Plavix Review and Plavix Label ), PAROXETINE HCL (Od) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), LEXOTAN (Od) (View Lexotan Review and Lexotan Label ). Patient was hospitalized.

6945090-7 | Pneumonia, Pulmonary Oedema, Transient Ischaemic Attack
Patient was taking Symbicort (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?), pulmonary oedema, transient ischaemic attack on Aug 19, 2010 from UNITED STATES Additional patient health information: Female patient , 74 years of age, weighting 200.0 lb, . Symbicort dosage: . During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), XOPENEX (View Xopenex Review and Xopenex Label ), FLEXERIL (View Flexeril Review and Flexeril Label ). Patient was hospitalized.

6944865-8 | Anaemia, Pancytopenia
Adverse event was reported on Aug 18, 2010 by a Male patient taking Symbicort (View Usage) (Dosage: ) . Location: JAPAN , 79 years of age, After Symbicort was administered, patient had the following side effects: anaemia, pancytopenia. Patient was hospitalized.

6943342-8 | Candidiasis, Nervousness, Oropharyngeal Blistering, Respiratory Disorder
on Aug 17, 2010 Female patient from UNITED STATES , 62 years of age, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: candidiasis, nervousness, oropharyngeal blistering, respiratory disorder. Symbicort dosage: . During the same period patient was treated with ADVAIR DISKUS 100/50 (500/50mcg, One Puff Twice Daily) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), SALBUTAMOL SULFATE (View Salbutamol Sulfate Review and Salbutamol Sulfate Label ). Patient was hospitalized.

6942645-0 | Appendicectomy
on Aug 17, 2010 Female patient from UNITED STATES , 67 years of age, weighting 145.9 lb, was diagnosed with emphysema and was treated with Symbicort (View Usage). Patient had the following side effects: appendicectomy. Symbicort dosage: 640 Mcg. During the same period patient was treated with COMBIVENT (View Combivent Review and Combivent Label ). Patient was hospitalized.

6942119-7 | Headache, Muscle Twitching, Nausea, Palpitations
Patient was taking Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: headache (What is headache?), muscle twitching, nausea (What is nausea?), palpitations on Aug 19, 2010 from AUSTRALIA Additional patient health information: Male patient , 64 years of age, . Symbicort dosage: .

6940763-4 | Dizziness, Heart Valve Replacement
Adverse event was reported on Aug 16, 2010 by a Male patient taking Symbicort (View Usage) (Dosage: 640 Ug Total Daily Dose) was diagnosed with pleural fibrosis, hypertension, reflux oesophagitis, hypercholesterolaemia and. Location: UNITED STATES , 83 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), heart valve replacement. During the same period patient was treated with ENALOPRIL (View Enalopril Review and Enalopril Label ), SODIUM DOCUSATE (View Sodium Docusate Review and Sodium Docusate Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), NIZATIDINE (View Nizatidine Review and Nizatidine Label ), CARBEDILOL (View Carbedilol Review and Carbedilol Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6940756-7 | Dysuria, Pollakiuria, Urinary Hesitation
on Aug 16, 2010 Male patient from UNITED STATES , weighting 220.0 lb, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). Patient had the following side effects: dysuria, pollakiuria, urinary hesitation. Symbicort dosage: 160/4.5 Ug 2 Puffs Bid. During the same period patient was treated with CHOLESTEROL (View Cholesterol Review and Cholesterol Label ), TRIGLYCERIDE PILLS (View Triglyceride Pills Review and Triglyceride Pills Label ), SINGULAIR (View Singulair Review and Singulair Label ).

6936682-X | Ill-defined Disorder, Pruritus, Rash
on Aug 12, 2010 Male patient from UNITED STATES , 81 years of age, was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: ill-defined disorder, pruritus, rash (What is rash?). Symbicort dosage: 160/4.5 Mcg, Two Puffs. During the same period patient was treated with VERAPAMIL (View Verapamil Review and Verapamil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), XOPENEX (View Xopenex Review and Xopenex Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ). Patient was hospitalized.

6936103-7 | Anaemia, Blood Disorder
Patient was taking Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood disorder on Aug 12, 2010 from UNITED STATES Additional patient health information: Female patient , 79 years of age, was diagnosed with asthma (What is asthma?) and. Symbicort dosage: 160/4.5 Mcg. Patient was hospitalized.

6933809-0 | Dyspnoea, Palpitations
Adverse event was reported on Jul 27, 2010 by a Female patient taking Symbicort (View Usage) (Dosage: 160/4.5 Ug) was diagnosed with asthma (What is asthma?) and. Location: SAUDI ARABIA , weighting 116.8 lb, Patient had the following side effects: dyspnoea, palpitations.

6933700-X | Oesophageal Haemorrhage, Off Label Use
on Aug 16, 2010 Female patient from BRAZIL , 81 years of age, weighting 123.5 lb, was diagnosed with lung disorder and was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: oesophageal haemorrhage, off label use. Symbicort dosage: 320/9 Mcg.

6933032-X | Abasia, Asthenia, Back Pain, Dermatomyositis, Dysgraphia, Dyspepsia, Dysphemia, Dyspnoea
on Aug 18, 2010 Female patient from UNITED STATES , 52 years of age, weighting 157.4 lb, was diagnosed with asthma (What is asthma?), cystic fibrosis and was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, asthenia, back pain (What is back pain?), dermatomyositis, dysgraphia, dyspepsia, dysphemia, dyspnoea. Symbicort dosage: Symbicort 2 Puffs Astra-zeneca 160-4. Bid Respiratory (054) P Albuterol/atrovent. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), ATROVENT (View Atrovent Review and Atrovent Label ).

6931008-X | Pneumonia
Patient was taking Symbicort (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?) on Aug 09, 2010 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 199.1 lb, . Symbicort dosage: 160/4.5, 2 Puffs. During the same period patient was treated with PROAIR HFA (View Proair Hfa Review and Proair Hfa Label ), WARFARIN (View Warfarin Review and Warfarin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), UROXATRAL (View Uroxatral Review and Uroxatral Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), AVODART (View Avodart Review and Avodart Label ). Patient was hospitalized.

6930224-0 | Aneurysm, Chronic Obstructive Pulmonary Disease
Adverse event was reported on Aug 10, 2010 by a Female patient taking Symbicort (View Usage) (Dosage: 160/4.5 Mcg Two Puffs Two Times A Day) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 67 years of age, After Symbicort was administered, patient had the following side effects: aneurysm (What is aneurysm?), chronic obstructive pulmonary disease. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

6928273-1 | Palpitations, Syncope
on Aug 12, 2010 Female patient from POLAND , 37 years of age, weighting 143.3 lb, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: palpitations, syncope. Symbicort dosage: . During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ).

6928004-5 | Dyspnoea, Fatigue, Somnolence
on Jul 01, 2010 Female patient from SAUDI ARABIA , weighting 114.6 lb, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). Patient had the following side effects: dyspnoea, fatigue, somnolence. Symbicort dosage: 160/4.5 Ug.

6927786-6 | Dyspnoea, Palpitations
Patient was taking Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: dyspnoea, palpitations on Jul 01, 2010 from SAUDI ARABIA Additional patient health information: Female patient , weighting 116.8 lb, was diagnosed with asthma (What is asthma?) and. Symbicort dosage: 160/4.5 Ug.

6925006-X | Hypokalaemia, Pharyngitis, Pneumonia
Adverse event was reported on Aug 06, 2010 by a Female patient taking Symbicort (View Usage) (Dosage: ) was diagnosed with asthma (What is asthma?) and. Location: JAPAN , 62 years of age, weighting 103.6 lb, Patient experienced the following unwanted or unexpected effects: hypokalaemia, pharyngitis, pneumonia (What is pneumonia?). During the same period patient was treated with SINGULAIR (10 Mg Daily) (View Singulair Review and Singulair Label ), MUCOSOLVAN (45 Mg Daily) (View Mucosolvan Review and Mucosolvan Label ), MEDICON (45 Mg Daily) (View Medicon Review and Medicon Label ), MUCODYNE (750 Mg Daily) (View Mucodyne Review and Mucodyne Label ).

6924585-6 | Hepatomegaly, Splenomegaly, Thrombocytopenia
on Aug 12, 2010 Female patient from FRANCE , weighting 130.1 lb, was diagnosed with bronchitis (What is bronchitis?), contraception, pain (What is pain?) and was treated with Symbicort (View Usage). Patient had the following side effects: hepatomegaly, splenomegaly, thrombocytopenia. Symbicort dosage: One Inhalation Two Times A Day. During the same period patient was treated with SPEDIFEN (View Spedifen Review and Spedifen Label ). Patient was hospitalized.

6922765-7 | Anosmia, Nasal Polyps
on Aug 04, 2010 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: anosmia, nasal polyps. Symbicort dosage: 160/4.5 Mcg 1 Puff. During the same period patient was treated with ESTRADIAL (View Estradial Review and Estradial Label ), PROAIR HFA (View Proair Hfa Review and Proair Hfa Label ), BENADRYL (View Benadryl Review and Benadryl Label ). Patient was hospitalized.

6922552-X | Asthma, Bronchopneumonia
Patient was taking Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), bronchopneumonia on Aug 04, 2010 from JAPAN Additional patient health information: Male patient , 72 years of age, weighting 143.3 lb, was diagnosed with asthma (What is asthma?) and. Symbicort dosage: 160/4.5 ?g One Inhalation. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

6921746-7 | Compression Fracture, Fall
Adverse event was reported on Aug 03, 2010 by a Female patient taking Symbicort (View Usage) (Dosage: 320 Mcgs Two Puffs) . Location: UNITED STATES , 90 years of age, weighting 117.9 lb, Patient had the following side effects: compression fracture, fall (What is fall?). Patient was hospitalized.

6918827-0 | Suicide Attempt
on Jul 30, 2010 Male patient from UNITED STATES , 46 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: suicide attempt. Symbicort dosage: 160/4.5 Two Puffs Twice A Day. Patient was hospitalized.

6914807-X | Hospitalisation, Suicide Attempt
on Jul 30, 2010 Male patient from UNITED STATES , 46 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: hospitalisation, suicide attempt. Symbicort dosage: 160/4.5 Two Puffs Twice A Day. Patient was hospitalized.

6913441-5 | Myocardial Infarction
Patient was taking Symbicort (View Usage). Patient had the following side effects: myocardial infarction on Aug 05, 2010 from UNITED STATES Additional patient health information: Male patient , 60 years of age, . Symbicort dosage: . During the same period patient was treated with COMBIVENT (View Combivent Review and Combivent Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ).